Clinical Trial Update: Special Use - Results Surveillance on Long-term Use With Wegovy®

View source ↗

Summary

A post-market surveillance study evaluating long-term use of Wegovy (semaglutide) for obesity. The trial status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Status: ACTIVE_NOT_RECRUITING